Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
20.6M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+815K
-
Total reported value, excl. options
-
$68.5M
-
Value change
-
+$4.87M
-
Number of buys
-
32
-
Number of sells
-
-10
-
Price
-
$6.11
Significant Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) as of Q2 2025
46 filings reported holding ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share as of Q2 2025.
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 20.6M outstanding shares and own 54.41% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (9.97M shares), Voss Capital, LP (286K shares), VANGUARD GROUP INC (264K shares), BlackRock, Inc. (195K shares), GEODE CAPITAL MANAGEMENT, LLC (118K shares), NORTHERN TRUST CORP (85.7K shares), BARCLAYS PLC (37.3K shares), STATE STREET CORP (31.4K shares), NORTHWESTERN UNIVERSITY (27.8K shares), and Gleason Group, Inc. (19K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.